Albany Molecular beats Street estimates

Drug discovery service provider AMRI posted fourth quarter EPS of $0.22, beating by $0.02 the Street's estimate of $0.20. Fourth quarter revenues increased 57 percent to $19.2 million, up from $12.2 m...